MG53 compositions and methods of use
US7981866B2 · kind B2 · utility
7Cited by
1References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2007 |
| Grant date | Jul 19, 2011 |
| Priority date | — |
| Expiry date | Aug 30, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.